War of words heats up in GPO controversy

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

advertisement
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments
advertisement

 

advertisement

 

More Industry Headlines

The rise of medical device hacking: How strong is your network security? In Q3 of 2018 alone, 4.4 million medical records were compromised

Balancing AI and the human touch with two new approaches Technology shouldn't sacrifice the clinician-patient relationship

Patients like the idea of telemedicine, but what about physicians? New study examines U.S. physician interest in telemedicine

Research shows how hurricanes hinder radiotherapy outcomes Treatment transfers and eliminating out-of-network insurance charges could help

Intuitive acquires Schölly Fiberoptic's robotic endoscope business Enhances supply chain, raises manufacturing capacity for imaging devices

Siemens forms $113 million alliance with UM System and MU Health Care The 10-year partnership will focus on improved care delivery and research

CMS proposes alternative payment model for radiation oncology Uses prospective, episode-based payments; ensures value-based care

Elekta to distribute C-RAD SIGRT technology in North America and Mexico Advances stereotactic radiosurgery and stereotactic body radiotherapy

Misdiagnosis behind a third of malpractice cases Researchers from Johns Hopkins look at 55,000 malpractice claims

With stock value up 51 percent, is Mindray too pricey? Valuation has recently soared to $29 billion

War of words heats up in GPO controversy

by Brendon Nafziger , DOTmed News Associate Editor

The researchers based their estimates on potential cost-savings outside of GPOs by using data from from MEMdata, a service that works with hospitals trying to buy capital equipment. The researchers compared prices in so-called aftermarket auctions, in which GPO-contract vendors bid with contract prices against other vendors.

"We looked at price of medical supplies after GPOs have ostensibly secured best price," Singer said. "If original GPO auctions are done efficiently, [there's] no price room."
Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs




But in the report the researchers said that on average, through the 8,100 auctions studied, the winning bid was 10 to 14 percent cheaper than the original GPO price over the 10 years of data they had available. The average GPO price was $81,436, but the average winning bid was $73,990, according to the authors.

"Indeed, in [more than] half of all auctions in the transactions database, incumbent device makers on the GPO contract were induced to lower their own prices for the same product to the same hospital, and did so by approximately 7 percent on average," the report said.

GPOs call data 'discredited'
But the GPOs feel they have been vindicated by most non-industry studies. HIGPA said the data in the MDMA study have long been "discredited" by reams of earlier reports, including an Eight Circuit Court finding from August that upheld a verdict favoring C.R. Bard's contract with the GPO Novation. The court said it found hospitals pay, on average, 16 percent less for supplies through GPOs.

Plus, a much-touted report published by the GAO last week found that hospitals increasingly rely on GPOs as the primary means to help keep the costs of medical products and services balanced. In addition, the GAO found that most device vendors found voluntarily adopted rules by the GPOs helped keep administrative fees low and transparent. Three out of five vendors interviewed for the report said they are now paying lower administrative fees and that fees are more consistent and predictable, according to the report.

"Because medical device manufacturers did not like what the U.S. Government Accountability Office found in its most recent analysis of the group purchasing industry, MDMA has chosen to disregard or manipulate the GAO report for its own purposes," Rooney said.

But Bob Yancy, the CEO of MEMdata, from which the raw data from the MDMA study came, was quick to say the report should not be interpreted as an attack on GPOs. For decades, GPOs helped control supply prices and "drove price efficiency in our health care system," he noted.
<< Pages: 1 - 2 - 3 >>

Related: